|
Jan 17
|
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
|
|
Jan 16
|
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
|
|
Jan 2
|
Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Jan 1
|
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
|
|
Nov 1
|
November 2024's Top US Penny Stocks With Growth Potential
|
|
Aug 29
|
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
|
|
Jul 29
|
Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss
|
|
May 31
|
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
|
|
May 29
|
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
|
May 9
|
Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations
|
|
May 8
|
Why Adaptive Biotechnologies Topped the Market Today
|
|
May 8
|
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 7
|
Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics
|
|
May 7
|
Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges
|
|
May 7
|
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 7
|
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
|
|
Apr 26
|
PhaseV and Quanticate partner to help sponsors run more adaptive trials
|
|
Apr 17
|
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
|
|
Apr 2
|
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
|